• Valour is partnering with Autostock, a Swedish trading platform, to launch an automated trading strategy designed to capture the weekly effects of Bitcoin
  • Autostock AB is a Swedish analysis/trading platform offering advanced technical analysis methods, automated trading facilities and algorithmic strategies
  • Valour offers fully hedged digital asset ETPs with low to zero management fees, with product listings across European exchanges, banks and broker platforms
  • Valour Inc. (DEFI) opened trading at C$0.145

Valour (DEFI) announced a partnership with Autostock, a Swedish trading platform.

Valour and Autostock have agreed to an exclusive partnership specific to digital assets, making it possible for Autostock clients to monitor the weekly effect of Bitcoin price development using Coinbot Zero by Valour.

Marco Infuso, Chief Sales Officer at Valour, commented on the news.

“Coinbot Zero by Valour executes within the ISK or Kapitalförsäkring-wrapper on Nordnet in Sweden and utilizes Valour Bitcoin ZERO SEK (CH0585378661), making it a perfect match for a first-of-its-kind program as it precisely tracks the price of Bitcoin. Another step towards crypto adoption – the democratization of the entire crypto ecosystem at its best!”.

Rikard Nilsson, CEO of Autostock, added,

“Stepping into the digital assets space, with an automated strategy specifically designed to capture the weekly effects of Bitcoin, is a first for Autostock. Partnering with Valour and using their Bitcoin ETP, without management fees, creates a unique opportunity and is the perfect choice for our clients.”

Valour, a technology company bridging the gap between traditional capital markets and decentralized finance, offers fully hedged digital asset ETPs with low to zero management fees, with product listings across European exchanges, banks and broker platforms.

Valour Inc. (DEFI) opened trading at C$0.145.


More From The Market Online
stock market down

@ the Bell: TSX hits near-month high

The TSX rose near highs not seen in a month, but a split between indices capped gains as mining and energy were the only…

FSD Pharma submits MS treatment clinical trial for review in Australia

FSD Pharma (CSE:HUGE) submits its MS treatment's Phase-1 Multiple Ascending Doses Clinical Trial Application for ethics review in Australia.

Cloud DX signs fourth contract with a provincial health authority

Cloud DX (TSXV:CDX) signs its fourth contract with a provincial health authority for remote patient monitoring.

International Petroleum stock rallies on Q1 results

Canadian energy stock International Petroleum Corp. (TSX:IPCO) rose in Tuesday trading on its Q1 2024 financial...